NCT02907788View on ClinicalTrials.gov

Inflammatory Markers in Broncho-alveolar Lavage Fluid as Risk Factors for Lung Disease in Infants With Cystic Fibrosis: the I-BALL Study

CompletedOBSERVATIONAL
Enrollment

51

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
Cystic Fibrosis
Trial Locations (1)

3015 CN

Erasmus MC -Sophia childrens hospital, Rotterdam

Sponsors
All Listed Sponsors
collaborator

Emory University

OTHER

collaborator

UMC Utrecht

OTHER

lead

Erasmus Medical Center

OTHER